Primary |
Drug Use For Unknown Indication |
26.2% |
Product Used For Unknown Indication |
20.8% |
Drug Exposure During Pregnancy |
7.7% |
Bladder Disorder |
4.6% |
Hypertonic Bladder |
4.6% |
Enuresis |
3.8% |
Incontinence |
3.8% |
Micturition Urgency |
3.8% |
Urinary Incontinence |
3.8% |
Panic Attack |
3.1% |
Hypertension |
2.3% |
Multiple Sclerosis |
2.3% |
Suicide Attempt |
2.3% |
Benign Prostatic Hyperplasia |
1.5% |
Bladder Spasm |
1.5% |
Drug Abuse |
1.5% |
Hyperhidrosis |
1.5% |
Micturition Disorder |
1.5% |
Prophylaxis |
1.5% |
Pruritus |
1.5% |
|
Urinary Tract Infection |
9.7% |
Angioedema |
6.5% |
Drug Ineffective |
6.5% |
Pruritus |
6.5% |
Pulmonary Hypertension |
6.5% |
Substance Abuse |
6.5% |
Syncope |
6.5% |
Talipes |
6.5% |
Ulcerative Keratitis |
6.5% |
Weight Gain Poor |
6.5% |
Adverse Event |
3.2% |
Anaphylactic Shock |
3.2% |
Basal Cell Carcinoma |
3.2% |
Blood Culture Positive |
3.2% |
Cognitive Disorder |
3.2% |
Convulsion |
3.2% |
Cyanosis |
3.2% |
Death |
3.2% |
Hypersensitivity |
3.2% |
Hyponatraemia |
3.2% |
|
Secondary |
Product Used For Unknown Indication |
24.9% |
Drug Use For Unknown Indication |
8.7% |
Multiple Sclerosis |
7.8% |
Hypertonic Bladder |
6.2% |
Pain |
6.2% |
Hypertension |
5.6% |
Diabetes Mellitus |
5.4% |
Urinary Incontinence |
4.7% |
Blood Cholesterol Increased |
4.1% |
Micturition Disorder |
3.7% |
Incontinence |
3.5% |
Fatigue |
3.3% |
Pyramidal Tract Syndrome |
2.5% |
Depression |
2.1% |
Ill-defined Disorder |
2.1% |
Micturition Urgency |
2.1% |
Bladder Disorder |
1.9% |
Neuropathy Peripheral |
1.9% |
Oligodendroglioma |
1.9% |
Hypercholesterolaemia |
1.6% |
|
Talipes |
15.9% |
Drug Ineffective |
9.1% |
Insomnia |
8.0% |
Dry Mouth |
6.8% |
Fall |
5.7% |
Inappropriate Antidiuretic Hormone Secretion |
5.7% |
Somnolence |
5.7% |
Drug Hypersensitivity |
4.5% |
Urinary Incontinence |
4.5% |
Convulsion |
3.4% |
Dyspepsia |
3.4% |
Overdose |
3.4% |
Premature Labour |
3.4% |
Renal Failure |
3.4% |
Vacterl Syndrome |
3.4% |
Viith Nerve Paralysis |
3.4% |
Weight Increased |
3.4% |
Bradycardia |
2.3% |
Confusional State |
2.3% |
Constipation |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
29.7% |
Drug Use For Unknown Indication |
13.2% |
Multiple Sclerosis |
11.8% |
Pain |
7.1% |
Hypertension |
5.5% |
Depression |
4.7% |
Diabetes Mellitus |
3.4% |
Osteoporosis |
3.0% |
Hypertonic Bladder |
2.6% |
Gastrooesophageal Reflux Disease |
2.5% |
Rheumatoid Arthritis |
2.4% |
Anxiety |
2.2% |
Asthma |
1.7% |
Prophylaxis |
1.6% |
Arthritis |
1.6% |
Atrial Fibrillation |
1.4% |
Hypothyroidism |
1.4% |
Relapsing-remitting Multiple Sclerosis |
1.4% |
Blood Cholesterol Increased |
1.4% |
Insomnia |
1.3% |
|
Vomiting |
13.1% |
Urinary Tract Infection |
12.1% |
Weight Decreased |
9.7% |
Weight Increased |
9.0% |
Renal Failure |
5.4% |
Drug Ineffective |
4.5% |
Tremor |
4.3% |
Pneumonia |
3.9% |
White Blood Cell Count Decreased |
3.7% |
Progressive Multifocal Leukoencephalopathy |
3.6% |
Myocardial Infarction |
3.4% |
Oedema Peripheral |
3.4% |
Nausea |
3.2% |
Pain |
3.2% |
Pain In Extremity |
3.2% |
Somnolence |
3.0% |
Urinary Incontinence |
3.0% |
Death |
2.8% |
Fall |
2.8% |
Fatigue |
2.8% |
|
Interacting |
Product Used For Unknown Indication |
20.0% |
Back Pain |
12.0% |
Pain |
12.0% |
Prostatomegaly |
12.0% |
Bladder Disorder |
4.0% |
Depression |
4.0% |
Drug Use For Unknown Indication |
4.0% |
Erectile Dysfunction |
4.0% |
Hypertonic Bladder |
4.0% |
Multiple Sclerosis |
4.0% |
Musculoskeletal Chest Pain |
4.0% |
Musculoskeletal Pain |
4.0% |
Pollakiuria |
4.0% |
Urinary Incontinence |
4.0% |
Vomiting |
4.0% |
|
Visual Impairment |
23.1% |
Drug Interaction |
15.4% |
Dyspnoea |
7.7% |
Faecaloma |
7.7% |
Inappropriate Schedule Of Drug Administration |
7.7% |
Incorrect Dose Administered |
7.7% |
Migraine |
7.7% |
Ultrasound Scan Abnormal |
7.7% |
Urinary Hesitation |
7.7% |
Urinary Tract Infection |
7.7% |
|